Key molecular events in cervical cancer development

SD Balasubramaniam, V Balakrishnan, CE Oon… - Medicina, 2019 - mdpi.com
Cervical cancer is the fourth most common cancer among women. Infection by high-risk
human papillomavirus (HPV) is the main aetiology for the development of cervical cancer …

Papillomavirus immune evasion strategies target the infected cell and the local immune system

C Zhou, ZK Tuong, IH Frazer - Frontiers in oncology, 2019 - frontiersin.org
Persistent infection with human papillomavirus (HPV) initiates~ 5% of all human cancers,
and particularly cervical and oropharyngeal cancers. HPV vaccines prevent HPV infection …

Regulatory T cells in cancer

D Mougiakakos, A Choudhury, A Lladser… - Advances in cancer …, 2010 - Elsevier
At the present time, regulatory T cells (Tregs) are an integral part of immunology but the
route from discovery of “suppressive” lymphocytes in the 1980s to the current established …

Immunotherapy Against HPV16/18 Generates Potent TH1 and Cytotoxic Cellular Immune Responses

ML Bagarazzi, J Yan, MP Morrow, X Shen… - Science translational …, 2012 - science.org
Despite the development of highly effective prophylactic vaccines against human
papillomavirus (HPV) serotypes 16 and 18, prevention of cervical dysplasia and cancer in …

Regulatory T cells in the control of host-microorganism interactions

Y Belkaid, K Tarbell - Annual review of immunology, 2009 - annualreviews.org
Each microenvironment requires a specific set of regulatory elements that are finely and
constantly tuned to maintain local homeostasis. Various populations of regulatory T cells …

Clinician's guide to human papillomavirus immunology: knowns and unknowns

MH Einstein, JT Schiller, RP Viscidi… - The Lancet infectious …, 2009 - thelancet.com
Oncogenic human papillomavirus (HPV) is a common genital infection that has the potential
to develop into cervical cancer in some women. This Review summarises current knowledge …

Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response

A Amador-Molina, JF Hernández-Valencia, E Lamoyi… - Viruses, 2013 - mdpi.com
During the early stages of human papillomavirus (HPV) infections, the innate immune
system creates a pro-inflammatory microenvironment by recruiting innate immune cells to …

Therapeutic HPV vaccines

G Hancock, K Hellner, L Dorrell - … practice & research Clinical obstetrics & …, 2018 - Elsevier
Highlights•Current prophylactic vaccines protect only against infection with high risk types
HPV16 and 18.•Several new platform technologies are being applied to the development of …

Regulatory T cells and treatment of cancer

TJ Curiel - Current opinion in immunology, 2008 - Elsevier
CD4+ CD25+ FOXP3+ regulatory T cells (Tregs) are elevated in cancers and can thwart
protective antitumor immunity. Recent human cancer trials suggest that depleting Tregs can …

High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients …

AM Heeren, BD Koster, S Samuels, DM Ferns… - Cancer immunology …, 2015 - AACR
A better understanding of the microenvironment in relation to lymph node metastasis is
essential for the development of effective immunotherapeutic strategies against cervical …